Skanska Gets SEK3.7 Billion Contract From AstraZeneca in the U.K.
February 18 2015 - 5:52AM
Dow Jones News
By Christina Zander
STOCKHOLM--Swedish builder Skanska (SKA-B.SK) said Wednesday it
won a SEK3.7 billion ($442 million) contract for the construction
management of a research and development center and corporate
headquarters for AstraZeneca PLC in the U.K.
The contract will be included in the order bookings for Skanska
U.K. in the first quarter of 2015.
Work has started and is expected to be completed in 2017. The
client will begin occupying the site at the end of 2016.
At 0954, shares were up 1.8% at SEK207.10
Write to Christina Zander at christina.zander@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Aug 2024 to Sep 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Sep 2023 to Sep 2024
